The molecular pathogenesis of classical Hodgkin lymphoma;Die molekulare pathogenese des klassischen hodgkin-lymphoms

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 39, 2009, Pages 1944-1948

  Mathas, S ^a,b   Dorken B ^a,b   Janz, M ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Apoptosis; B cell differentiation; Hodgkin lymphoma; HRS cells

Indexed keywords

JANUS KINASE; MYC PROTEIN; PROTEIN BCL 6; PROTEIN KINASE PIM 1; STAT PROTEIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; S6 KINASE;

APOPTOSIS; B LYMPHOCYTE DIFFERENTIATION; GENE MUTATION; HODGKIN DISEASE; HUMAN; NONHODGKIN LYMPHOMA; REVIEW; B LYMPHOCYTE; GENETICS; PATHOLOGY; PHYSIOLOGY; REED STERNBERG CELL; SIGNAL TRANSDUCTION;

APOPTOSIS; B-LYMPHOCYTES; CYTOKINES; HODGKIN DISEASE; HUMANS; NF-KAPPA B; REED-STERNBERG CELLS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 70349580097     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1237537     Document Type: Review

References (47)

1. Atayar C, Poppema S, Blokzijl T, Harms G, Boot M, van den Berg A. Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas. Am J Pathol 2005; 166: 127-134
2. Bargou R C., Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkins disease tumor cells. J Clin Invest 1997; 100: 2961-2969
3. Bräuninger A, Hansmann M L., Strickler J G., et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkins disease and non-Hodgkins lymphoma. N Engl J Med 1999; 340: 1239-1247
4. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 2007; 449: 473-477
5. Fiumara P, Snell V, Li Y, et al.Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 2001; 98: 2784-2790
6. Gandhi M K., Lambley E, Duraiswamy J, et al. Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood 2006; 108: 2280-2289
7. Hertel C B., Zhou X G., Hamilton-Dutoit S J., Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/ Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 2002; 21: 4908-4920
8. Hinz M, Lemke P, Anagnostopoulos I,et al. Nuclear factor appaB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 2002; 196: 605-617
9. Holtick U, Vockerodt M, Pinkert D, et al. STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis. Leukemia 2005; 19: 936-944
10. Ishida T, Ishii T, Inagaki A, et al. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res 2006; 66: 5716-5722
11. Joos S, Küpper M, Ohl S, et al. Genomic imbalances including plification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000; 60: 549-552
12. Jundt F, Acikgöz Ö, Kwon S H., et al. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. Leukemia 2008; 22: 1587-1594
13. Jundt F, Anagnostopoulos I, Bommert K, et al. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 1999; 94: 2065-2071
14. Jundt F, Anagnostopoulos I, Förster R, Mathas S, Stein H, Dörken B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 2002; 99: 3398-3403
15. Jundt F, Kley K, Anagnostopoulos I, et al. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood 2002; 99: 3060-3062
16. Juszczynski P, Ouyang J, Monti S, et al. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci U S A 2007; 104:13134-13139
17. Kanzler H, Küppers R, Hansmann M L., Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkins disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495-1505
18. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9: 240-246
19. Klein U, Dalla-Favera R. Germinal centres: Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8: 22-33
20. Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B, Scheidereit C. Molecular mechanisms of constitutive NF-kappaB/Rel activationin Hodgkin/Reed-Sternberg cells. Oncogene 1999; 18: 943-953
21. Küppers R. The biology of Hodgkins lymphoma. Nat Rev Cancer 2009; 9: 15-27
22. Küppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001; 20: 5580-5594
23. Küppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003; 111: 529-537 (Pubitemid 36228010)
24. Küppers R, Rajewsky K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkins disease. Annu Rev Immunol 1998; 16: 471-493 (Pubitemid 28183373)
25. Marafioti T, Hummel M, Anagnostopoulos I, Foss H D., Huhn D, Stein H. Classical Hodgkins disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 1999; 17: 3804-3809
26. Marafioti T, Hummel M, Foss H D., et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443-1450
27. Mathas S, Hinz M, Anagnostopoulos I, et al. et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. Embo J 2002; 21: 4104-4113
28. Mathas S, Janz M, Hummel F, et al. Intrinsic inhibition of ranscription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006; 7: 207-215
29. Mathas S, Lietz A, Janz M, et al. Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis. Blood 2003; 102: 1028-1034
30. Mullighan C G., Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007;446: 758-764
31. Müschen M, Rajewsky K, Bräuninger A, et al. Rare occurrence of classical Hodgkins disease as a T cell lymphoma. J Exp Med 2000; 191: 387-394
32. Portis T, Dyck P, Longnecker R.Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003; 102: 4166-4178
33. Renné C, Martin-Subero J I., Eickernjäger M, et al. Aberrant xpression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkins ymphoma. Am J Pathol 2006; 169: 655-664
34. Rothenberg E V., Moore J E., Yui M A. Launching the T-cell-lineage developmental programme. Nat Rev Immunol 2008; 8: 9-21
35. Scheeren F A., Diehl S A., Smit L A., et al. IL-21 is expressed in Hodgkin Lymphoma and activates STAT5; evidence that activated STAT5 is required for Hodgkin Lymphomagenesis. Blood 2008; 111: 4706-4715
36. Skinnider B F., Elia A J., Gascoyne R D., et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002; 99: 618-626
37. Skinnider B F., Elia A J., Gascoyne R D., et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2001; 97: 250-255
38. Souabni A, Jochum W, Busslinger M. Oncogenic role of Pax5 in the Tlymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus. Blood 2007; 109: 281-289
39. Stein H, Delsol G, Pileri S. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, (Hrsg). World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid tissues. Lyon: IARC Press, 2001: 244-253
40. Stein H, Marafioti T, Foss HD et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001; 97: 496-501
41. Trieu Y, Wen X Y., Skinnider B F.,et al. Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkins lymphoma growth in vitro and in vivo. Cancer Res 2004; 64: 3271-3275
42. Ushmorov A, Leithäuser F, Sakk O, et al. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 2006; 107: 2493-2500
43. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27: 693-733
44. van den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkins lymphoma. Am J Pathol 1999; 154: 1685-1691
45. Vockerodt M, Morgan S L., Kuo M, et al. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkins Reed-Sternberg-like phenotype. J Pathol 2008; 216: 83-92
46. Watanabe M, Sasaki M, Itoh K, et al. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma. Cancer Res 2005; 65: 7628-7634
47. Weniger M A., Melzner I, Menz C K., et al. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 2006; 25: 2679-2684